TR200200631T2 - Alfa-2/Delta geni - Google Patents

Alfa-2/Delta geni

Info

Publication number
TR200200631T2
TR200200631T2 TR2002/00631T TR200200631T TR200200631T2 TR 200200631 T2 TR200200631 T2 TR 200200631T2 TR 2002/00631 T TR2002/00631 T TR 2002/00631T TR 200200631 T TR200200631 T TR 200200631T TR 200200631 T2 TR200200631 T2 TR 200200631T2
Authority
TR
Turkey
Prior art keywords
alpha
genes
gene
delta gene
polypeptides
Prior art date
Application number
TR2002/00631T
Other languages
English (en)
Inventor
Ann Johns Margaret
Moldover Brian
David Offord James
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of TR200200631T2 publication Critical patent/TR200200631T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Bu bulus, üç yeni gene ve bu genlerden türetilen, bir çok kalsiyum kanalinda bir alt-birim halinde varolan ''alfa2S-C'2 ve/veya ''alfa2SD'' proteinlerini kodlayan polipeptidlere iliskindir. Bulus, ayni zamanda, yeni gen ve polipeptidlerin, genin genetik silinmelerinin bulgulanmasinda, polipeptidin subselüler konumlanisinda kimyasal veri tabanlari ile baglantili baglanma tahlillerinde, gen terapisinde kullanilmasi için yöntemleri de anlatmaktadir.
TR2002/00631T 1998-10-07 1999-10-07 Alfa-2/Delta geni TR200200631T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10332298P 1998-10-07 1998-10-07
US10647398P 1998-10-30 1998-10-30
US11408898P 1998-12-29 1998-12-29

Publications (1)

Publication Number Publication Date
TR200200631T2 true TR200200631T2 (tr) 2002-06-21

Family

ID=27379516

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2001/00937T TR200100937T2 (tr) 1998-10-07 1999-10-07 Alfa-2/Delta geni
TR2002/00632T TR200200632T2 (tr) 1998-10-07 1999-10-07 Alfa-2/Delta Geni
TR2002/00571T TR200200571T2 (tr) 1998-10-07 1999-10-07 Alfa-2/delta geni
TR2002/00631T TR200200631T2 (tr) 1998-10-07 1999-10-07 Alfa-2/Delta geni

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2001/00937T TR200100937T2 (tr) 1998-10-07 1999-10-07 Alfa-2/Delta geni
TR2002/00632T TR200200632T2 (tr) 1998-10-07 1999-10-07 Alfa-2/Delta Geni
TR2002/00571T TR200200571T2 (tr) 1998-10-07 1999-10-07 Alfa-2/delta geni

Country Status (7)

Country Link
US (1) US7262052B1 (tr)
EP (1) EP1117796A2 (tr)
JP (1) JP2002526100A (tr)
AU (1) AU1106500A (tr)
CA (1) CA2341351A1 (tr)
TR (4) TR200100937T2 (tr)
WO (1) WO2000020450A2 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214599A2 (en) * 1999-09-16 2002-06-19 Warner-Lambert Company Screening for alpha2delta-1 subunit binding ligands
US6962973B1 (en) 1999-09-16 2005-11-08 Warner-Lambert Company Porcine α2δ-1 calcium channel subunit cDNA and soluble secreted α2δ-1 subunit polypeptides
US6783952B1 (en) * 1999-09-16 2004-08-31 Warner-Lambert Company Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same
AU2001255448A1 (en) 2000-04-17 2001-10-30 Stephen B. Liggett Alpha-2 adrenergic receptor polymorphisms
US20020081657A1 (en) * 2000-06-05 2002-06-27 Curtis Rory A.J. 21784, a novel human calcium channel family member and uses thereof
US7294691B1 (en) 2000-09-18 2007-11-13 Warner Lambert Company Soluble secreted α2δ-2calcium channel subunit polypeptide
US7524643B2 (en) 2001-04-11 2009-04-28 Ortho-Mcneil Pharmaceutical, Inc. CDNA encoding the human alpha2 delta4 calcium channel subunit
US7049084B2 (en) 2001-05-30 2006-05-23 Ortho-Mcneil Pharmaceutical, Inc. Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore
EP1802775B1 (en) 2004-09-14 2010-05-26 The Regents of the University of Colorado Method for treatment with bucindolol based on genetic targeting

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US6040436A (en) 1996-09-16 2000-03-21 American Home Products Corporation Nucleic acid encoding human neuronal calcium channel subunits
WO2000012711A2 (en) * 1998-09-02 2000-03-09 Incyte Pharmaceuticals, Inc. Human membrane channel proteins

Also Published As

Publication number Publication date
TR200100937T2 (tr) 2001-10-22
JP2002526100A (ja) 2002-08-20
TR200200571T2 (tr) 2002-06-21
WO2000020450A9 (en) 2001-04-05
AU1106500A (en) 2000-04-26
EP1117796A2 (en) 2001-07-25
WO2000020450A3 (en) 2000-11-23
WO2000020450A2 (en) 2000-04-13
CA2341351A1 (en) 2000-04-13
US7262052B1 (en) 2007-08-28
TR200200632T2 (tr) 2002-07-22

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
IL193886A (en) Antibodies that bind to ldcam sequences
TR200200631T2 (tr) Alfa-2/Delta geni
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
DE69808743D1 (en) Netrinrezeptoren
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
EP1005539A4 (en) IKK-ALPHA PROTEINS, NUCLEIC ACIDS AND METHOD
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
DK1009817T3 (da) RTD-receptor
WO2002066640A3 (en) Zinc finger binding domains for nucleotide sequence ann
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
ATE325876T1 (de) Isolierte peptide, die an hla-c moleküle binden und deren verwendung
IL153833A0 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
CA2311646A1 (en) Tsa305 gene
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
TW342413B (en) Novel toxins isolated from Bracon Hebetor
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
ATE332373T1 (de) Menschlisches il-1 epsilon dna und polypeptide
WO2000008178A3 (en) Murine dna molecules encoding polypeptides having kinase functions
NO20000345L (no) Humankloridionekanal-zsig44